Eurocine Vaccines AB (publ) announced earnings results for the quarter and full year ended June 30, 2021. For the quarter, the company reported loss after tax of SEK 6.0 million against SEK 2.5 million a year ago. Income for the quarter was SEK 2,000 against nil a year ago. Loss per share amounted to SEK 0.768 against SEK 0.479 a year ago. For the full year, the company reported loss after tax of SEK 18.3 million against SEK 9.2 million a year ago. Income for the quarter was SEK 459,000 against nil a year ago. Loss per share amounted to SEK 2,313 against SEK 2,809 a year ago.